(Q35912886)

11 August 2017

1 reference

title

Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts (English)

1 reference

11 August 2017

1 reference

Voulgarelis M

1

1 reference

11 August 2017

Giannouli S

series ordinal

2

1 reference

11 August 2017

Ritis K

series ordinal

3

1 reference

11 August 2017

Tzioufas AG

series ordinal

4

1 reference

11 August 2017

publication date

1 October 2004

1 reference

European Journal of Clinical Investigation

11 August 2017

published in

1 reference

11 August 2017

volume

34

1 reference

11 August 2017

issue

10

1 reference

11 August 2017

page(s)

690-700

1 reference

The myelodysplastic syndromes in 1996: complex stem cell disorders confounded by dual actions of cytokines.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Ineffective haemopoiesis and apoptosis in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Faces and phases of human CD8 T-cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Determination of T-cell receptors of clonal CD8-positive T-cells in myelodysplastic syndrome with erythroid hypoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

The pathophysiology of acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

IRF-1 as a negative regulator of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2004.01417.X

10.1111/J.1365-2362.2004.01417.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference